chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Product administered to patient of inappropriate age
Clinical narrative: Product administered to 16 year old; Fatigue, feeling wiped out; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 17-Jun-2021 and was forwarded to Moderna on 17-Jun-2021.    This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Product administered to 16 year old) and FATIGUE (Fatigue, feeling wiped out) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004C21A and 021B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Product administered to 16 year old) and FATIGUE (Fatigue, feeling wiped out). On 29-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Product administered to 16 year old) had resolved. On 30-Apr-2021, FATIGUE (Fatigue, feeling wiped out) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered FATIGUE (Fatigue, feeling wiped out) to be not related. No further causality assessment was provided for PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Product administered to 16 year old).    Patient reported no known allergies.  No information on concomitant medications was provided.  No information on treatment medications was provided.   This case was linked to MOD-2021-068994 (Patient Link).
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Syringe issue
Clinical narrative: Syringe broke during administration; This spontaneous case was reported by a pharmacist and describes the occurrence of SYRINGE ISSUE (Syringe broke during administration) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jun-2021, the patient experienced SYRINGE ISSUE (Syringe broke during administration). On 17-Jun-2021, SYRINGE ISSUE (Syringe broke during administration) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications reported. No treatment information was provided. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Duration between 2 doses > 42 days; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Duration between 2 doses > 42 days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Duration between 2 doses > 42 days). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Duration between 2 doses > 42 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The concomitant medications were not reported. The treatment information was not provided.  The reporter informed that the patient took first dose and second dose was scheduled on 11-JUN-2021.The patient will be will be available only after 12-JUL-2021.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Peripheral swelling
Clinical narrative: Shortness of breath; Swelling of feet; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath) and PERIPHERAL SWELLING (Swelling of feet) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M204A and 038K204) for COVID-19 vaccination.     Concurrent medical conditions included Chronic obstructive pulmonary disease. Concomitant products included FLUTICASONE PROPIONATE (PROAIR [FLUTICASONE PROPIONATE]), FORMOTEROL FUMARATE, MOMETASONE FUROATE (DULERA), TIOTROPIUM BROMIDE MONOHYDRATE (SPIRIVA RESPIMAT), MONTELUKAST SODIUM (SINGULAIR), DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]), LORATADINE, PSEUDOEPHEDRINE SULFATE (CLARITIN-D), ACETYLSALICYLIC ACID, CAFFEINE, SALICYLAMIDE (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;SALICYLAMIDE]), COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]), VITAMIN C [ASCORBIC ACID] and VITAMIN E [VITAMIN E NOS] for an unknown indication.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced DYSPNOEA (Shortness of breath) and PERIPHERAL SWELLING (Swelling of feet). At the time of the report, DYSPNOEA (Shortness of breath) and PERIPHERAL SWELLING (Swelling of feet) had not resolved.            No treatment information was reported. Action taken with mRNA-1273 in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 29-Jul-2021: Follow-up received on 29 Jul 2021, The follow-up document contains No New Information
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Arm was a little sore to the touch/arm was sore to touch/pain in his arm was excruciating; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was a little sore to the touch/arm was sore to touch/pain in his arm was excruciating) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046B21A and 025C21A) for COVID-19 vaccination.     Concomitant products included OXYCODONE for an unknown indication.   On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced PAIN IN EXTREMITY (Arm was a little sore to the touch/arm was sore to touch/pain in his arm was excruciating). At the time of the report, PAIN IN EXTREMITY (Arm was a little sore to the touch/arm was sore to touch/pain in his arm was excruciating) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication information was reported. The patient reported that the patient had back and neck issues and took oxycodone.       Most recent FOLLOW-UP information incorporated above includes: On 17-Jun-2021: Follow-up received does not contain any new information.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Confusional state, Dizziness, Dyspnoea, Loss of personal independence in daily activities, Palpitations
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Heart Palpitations), DIZZINESS (Feel dizzy), DYSPNOEA (Difficulty Breathing), CONFUSIONAL STATE (COVID fog and gets confused) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Can not multi-task) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045A21A and 044B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Cancer (History of cancer reported twice.) and Sickness (Dizziness, Shortness of breath, Bronchitis) in December 2019. On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PALPITATIONS (Heart Palpitations), DIZZINESS (Feel dizzy), DYSPNOEA (Difficulty Breathing), CONFUSIONAL STATE (COVID fog and gets confused), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Can not multi-task) and POST-ACUTE COVID-19 SYNDROME (Post COVID symptoms). At the time of the report, PALPITATIONS (Heart Palpitations) and POST-ACUTE COVID-19 SYNDROME (Post COVID symptoms) outcome was unknown and DIZZINESS (Feel dizzy), DYSPNOEA (Difficulty Breathing), CONFUSIONAL STATE (COVID fog and gets confused) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Can not multi-task) had not resolved. No relevant concomitant medications were reported. Treatment prescribed included IM antibiotics and inhaler for shortness of breath. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Post-acute COVID-19 syndrome
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Heart Palpitations), DIZZINESS (Feel dizzy), DYSPNOEA (Difficulty Breathing), CONFUSIONAL STATE (COVID fog and gets confused) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Can not multi-task) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045A21A and 044B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Cancer (History of cancer reported twice.) and Sickness (Dizziness, Shortness of breath, Bronchitis) in December 2019. On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PALPITATIONS (Heart Palpitations), DIZZINESS (Feel dizzy), DYSPNOEA (Difficulty Breathing), CONFUSIONAL STATE (COVID fog and gets confused), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Can not multi-task) and POST-ACUTE COVID-19 SYNDROME (Post COVID symptoms). At the time of the report, PALPITATIONS (Heart Palpitations) and POST-ACUTE COVID-19 SYNDROME (Post COVID symptoms) outcome was unknown and DIZZINESS (Feel dizzy), DYSPNOEA (Difficulty Breathing), CONFUSIONAL STATE (COVID fog and gets confused) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Can not multi-task) had not resolved. No relevant concomitant medications were reported. Treatment prescribed included IM antibiotics and inhaler for shortness of breath. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia
Clinical narrative: Very tired; Had a fever; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Very tired) and PYREXIA (Had a fever) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Hyperlipidaemia. Concomitant products included ATORVASTATIN and LISINOPRIL for an unknown indication.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Apr-2021, the patient experienced FATIGUE (Very tired) and PYREXIA (Had a fever). At the time of the report, FATIGUE (Very tired) and PYREXIA (Had a fever) outcome was unknown.            No treatment information was reported
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Dizziness, Gait disturbance, Pyrexia
Clinical narrative: Took me days to learn how to walk; Fuzziness the spinning of my head; Fever; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Took me days to learn how to walk), DIZZINESS (Fuzziness the spinning of my head) and PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced GAIT DISTURBANCE (Took me days to learn how to walk), DIZZINESS (Fuzziness the spinning of my head) and PYREXIA (Fever). At the time of the report, GAIT DISTURBANCE (Took me days to learn how to walk), DIZZINESS (Fuzziness the spinning of my head) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 104 (High) 104.         Action taken with mRNA-1273 in response to the events was not applicable. No concomitant medication information was provided No treatment medication information was provided   This case was linked to MOD-2021-137978 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: I prayed for death, my whole body was in terrific pain; This spontaneous case was reported by a nurse and describes the occurrence of PAIN (I prayed for death, my whole body was in terrific pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Jun-2021, the patient experienced PAIN (I prayed for death, my whole body was in terrific pain). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 02-Jun-2021, PAIN (I prayed for death, my whole body was in terrific pain) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.   Reporter did not allow further contact
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Computerised tomogram, Hypoaesthesia, Myalgia, Pain
Clinical narrative: Hand was tingling; Hand was numb; Felt deep in arm, radiating down to hand; Pain in his arm was excruciating; Arm was sore to touch; Distraught; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Hand was tingling), HYPOAESTHESIA (Hand was numb), PAIN (Felt deep in arm, radiating down to hand), ANXIETY (Distraught) and PAIN IN EXTREMITY (Pain in his arm was excruciating) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025C21A and 046B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Medical history was not provided.  Concomitant products included OXYCODONE for an unknown indication.   On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In May 2021, the patient experienced ANXIETY (Distraught). On 20-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MYALGIA (Arm was sore to touch). On 21-May-2021, the patient experienced PARAESTHESIA (Hand was tingling), HYPOAESTHESIA (Hand was numb), PAIN (Felt deep in arm, radiating down to hand) and PAIN IN EXTREMITY (Pain in his arm was excruciating). The patient was treated with LIDOCAINE at a dose of UNK dosage form and OXYCODONE at a dose of 1 UNK. At the time of the report, PARAESTHESIA (Hand was tingling), HYPOAESTHESIA (Hand was numb), PAIN (Felt deep in arm, radiating down to hand), ANXIETY (Distraught), PAIN IN EXTREMITY (Pain in his arm was excruciating) and MYALGIA (Arm was sore to touch) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-May-2021, Computerised tomogram: unknown (Inconclusive) results not provided. On 15-May-2021, X-ray: unknown (Inconclusive) results not provided.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications included steroids, both injections and oral and muscle relaxers.   This case was linked to MOD-2021-225680 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-Jun-2021: Follow-up received on 25-JUN-2021 contains no new information.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Paraesthesia, X-ray
Clinical narrative: Hand was tingling; Hand was numb; Felt deep in arm, radiating down to hand; Pain in his arm was excruciating; Arm was sore to touch; Distraught; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Hand was tingling), HYPOAESTHESIA (Hand was numb), PAIN (Felt deep in arm, radiating down to hand), ANXIETY (Distraught) and PAIN IN EXTREMITY (Pain in his arm was excruciating) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025C21A and 046B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Medical history was not provided.  Concomitant products included OXYCODONE for an unknown indication.   On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In May 2021, the patient experienced ANXIETY (Distraught). On 20-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MYALGIA (Arm was sore to touch). On 21-May-2021, the patient experienced PARAESTHESIA (Hand was tingling), HYPOAESTHESIA (Hand was numb), PAIN (Felt deep in arm, radiating down to hand) and PAIN IN EXTREMITY (Pain in his arm was excruciating). The patient was treated with LIDOCAINE at a dose of UNK dosage form and OXYCODONE at a dose of 1 UNK. At the time of the report, PARAESTHESIA (Hand was tingling), HYPOAESTHESIA (Hand was numb), PAIN (Felt deep in arm, radiating down to hand), ANXIETY (Distraught), PAIN IN EXTREMITY (Pain in his arm was excruciating) and MYALGIA (Arm was sore to touch) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-May-2021, Computerised tomogram: unknown (Inconclusive) results not provided. On 15-May-2021, X-ray: unknown (Inconclusive) results not provided.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications included steroids, both injections and oral and muscle relaxers.   This case was linked to MOD-2021-225680 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-Jun-2021: Follow-up received on 25-JUN-2021 contains no new information.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Administered vaccine after 12 hrs of 1st puncture of vial; Administered vaccine after 12 hrs of 1st puncture of vial; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered vaccine after 12 hrs of 1st puncture of vial) and PRODUCT STORAGE ERROR (Administered vaccine after 12 hrs of 1st puncture of vial) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered vaccine after 12 hrs of 1st puncture of vial) and PRODUCT STORAGE ERROR (Administered vaccine after 12 hrs of 1st puncture of vial). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered vaccine after 12 hrs of 1st puncture of vial) and PRODUCT STORAGE ERROR (Administered vaccine after 12 hrs of 1st puncture of vial) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided. Concomitant Products use was not provided by the reporter. Action taken for the suspect drug mRNA-1273 for the events is not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: administered >12 hours after vial puncture; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 16-Jun-2021 and was forwarded to Moderna on 17-Jun-2021.    Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered >12 hours after vial puncture) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered >12 hours after vial puncture). On 15-Jun-2021, EXPIRED PRODUCT ADMINISTERED (administered >12 hours after vial puncture) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: chills; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 17-Jun-2021 and was forwarded to Moderna on 17-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills). At the time of the report, CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported No treatment medications were provided  Action taken with mRNA-1273 in response to the events was unknown
Sex: U
Vaccine: COVID19
Symptoms: Parosmia
Clinical narrative: The chemical smell is still there it gets worse when I get active and sweat; This spontaneous case was reported by a patient and describes the occurrence of PAROSMIA (The chemical smell is still there it gets worse when I get active and sweat) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAROSMIA (The chemical smell is still there it gets worse when I get active and sweat). At the time of the report, PAROSMIA (The chemical smell is still there it gets worse when I get active and sweat) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details were reported. No treatment medication details was reported.   Most recent FOLLOW-UP information incorporated above includes: On 06-Aug-2021: Significant follow-up received, outcome of the event was updated.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity, Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: hotness; soreness; bump on arm; redness; mild headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hotness), PAIN IN EXTREMITY (soreness), VACCINATION SITE SWELLING (bump on arm), VACCINATION SITE ERYTHEMA (redness) and HEADACHE (mild headache) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 026L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE WARMTH (hotness), PAIN IN EXTREMITY (soreness), VACCINATION SITE SWELLING (bump on arm), VACCINATION SITE ERYTHEMA (redness) and HEADACHE (mild headache). At the time of the report, VACCINATION SITE WARMTH (hotness), PAIN IN EXTREMITY (soreness), VACCINATION SITE SWELLING (bump on arm), VACCINATION SITE ERYTHEMA (redness) and HEADACHE (mild headache) had not resolved.      Action taken with mRNA-1273 in response to the events was not applicable      Treatment included ice No concomitant medications information was reported    This case was linked to MOD-2021-221254 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 18-Jun-2021: Updated contact information  Email
Sex: U
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Very tired for one week; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of FATIGUE (Very tired for one week) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Jun-2021, the patient experienced FATIGUE (Very tired for one week). On 09-Jun-2021, FATIGUE (Very tired for one week) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   no concomitant and treatment drugs were provided.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Inappropriate schedule of product administration, Pyrexia
Clinical narrative: Had a little of fever that lasted less than 24Hours after the 2nd dose; Chills that lasted less than 24Hours after the 2nd dose; 2nd dose was given after 36 days; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Had a little of fever that lasted less than 24Hours after the 2nd dose), CHILLS (Chills that lasted less than 24Hours after the 2nd dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose was given after 36 days) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039C21A and 039B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Jun-2021, the patient experienced PYREXIA (Had a little of fever that lasted less than 24Hours after the 2nd dose), CHILLS (Chills that lasted less than 24Hours after the 2nd dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose was given after 36 days). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 14-Jun-2021, PYREXIA (Had a little of fever that lasted less than 24Hours after the 2nd dose) and CHILLS (Chills that lasted less than 24Hours after the 2nd dose) had resolved. At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose was given after 36 days) had resolved.            Concomitant medications was not reported.
Sex: U
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: report a side effect; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (report a side effect) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (report a side effect). At the time of the report, ADVERSE EVENT (report a side effect) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medication was reported
Sex: U
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Really bad headache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of HEADACHE (Really bad headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Jun-2021, the patient experienced HEADACHE (Really bad headache). On 09-Jun-2021, HEADACHE (Really bad headache) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were reported. No treatment information was reported  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Patient has not received the second dose within the appropriated window of time between two doses (first dose received 16Jan2021); This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient has not received the second dose within the appropriated window of time between two doses (first dose received 16Jan2021)) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient has not received the second dose within the appropriated window of time between two doses (first dose received 16Jan2021)). On 16-Jan-2021, PRODUCT DOSE OMISSION ISSUE (Patient has not received the second dose within the appropriated window of time between two doses (first dose received 16Jan2021)) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were mentioned.  No treatment details were reported.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Arthritis, Pain in extremity
Clinical narrative: Arthritis Flare up; Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRITIS (Arthritis Flare up) and PAIN IN EXTREMITY (Sore Arm) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 006B21A) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis.   On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Mar-2021, the patient experienced ARTHRITIS (Arthritis Flare up) and PAIN IN EXTREMITY (Sore Arm). At the time of the report, ARTHRITIS (Arthritis Flare up) and PAIN IN EXTREMITY (Sore Arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient stated that the event arthritis flare up was not related to his vaccine but rather because he had not taken extra strength Tylenol in 2 days after vaccination.   No concomitant information was reported. Treatment information was not reported.   This case was linked to MOD-2021-054307 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Rash, Rash vesicular, Skin discolouration
Clinical narrative: Dark and blistery rash; Dark and blistery rash; Rash on armpit and sides/Painful growing rash; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH VESICULAR (Dark and blistery rash), SKIN DISCOLOURATION (Dark and blistery rash) and RASH (Rash on armpit and sides/Painful growing rash) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jun-2021, the patient experienced RASH VESICULAR (Dark and blistery rash), SKIN DISCOLOURATION (Dark and blistery rash) and RASH (Rash on armpit and sides/Painful growing rash). The patient was treated with KETOCONAZOLE at an unspecified dose and frequency and FLUCONAZOLE at an unspecified dose and frequency. At the time of the report, RASH VESICULAR (Dark and blistery rash), SKIN DISCOLOURATION (Dark and blistery rash) and RASH (Rash on armpit and sides/Painful growing rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. Doctor told to patient it might be shingles or fungi infection; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event of vaccination site rash a causal relationship cannot be excluded. The event of rash was assessed as unrelated based on reporter causality.
Sex: U
Vaccine: COVID19
Symptoms: Pulmonary pain, Vaccination complication
Clinical narrative: my lungs hurt when i breathe in; COVID arm; This spontaneous case was reported by a consumer and describes the occurrence of PULMONARY PAIN (my lungs hurt when i breathe in) and VACCINATION COMPLICATION (COVID arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Pneumonia (Hospitalized for 2 weeks) in 2019.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PULMONARY PAIN (my lungs hurt when i breathe in) and VACCINATION COMPLICATION (COVID arm). At the time of the report, PULMONARY PAIN (my lungs hurt when i breathe in) and VACCINATION COMPLICATION (COVID arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product was not provided by the reporter.  Treatment information was not provided.  For mRNA-1273 (COVID 19 Vaccine Moderna), the reporter did not provide any causality assessments.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster, Rash
Clinical narrative: may be shingles; patient developed rashes on the right shoulder/at the beginning size of rash looked like index finger but now look like 3 fingers/ Some rashes are red with head and other are white clear; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (may be shingles) and RASH (patient developed rashes on the right shoulder/at the beginning size of rash looked like index finger but now look like 3 fingers/ Some rashes are red with head and other are white clear) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jun-2021, the patient experienced RASH (patient developed rashes on the right shoulder/at the beginning size of rash looked like index finger but now look like 3 fingers/ Some rashes are red with head and other are white clear). On an unknown date, the patient experienced HERPES ZOSTER (may be shingles). At the time of the report, HERPES ZOSTER (may be shingles) and RASH (patient developed rashes on the right shoulder/at the beginning size of rash looked like index finger but now look like 3 fingers/ Some rashes are red with head and other are white clear) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medication was provided.  Patient developed rashes on the right shoulder and at the beginning the size rash looked like index finger but now look like 3 fingers. Some rashes are red with head and other are white clear. The caller mentioned that may be shingles. She wanted to know what to do and asked medication to use.
Sex: U
Vaccine: COVID19
Symptoms: Rheumatic disorder
Clinical narrative: rheumatism flair up; This spontaneous case was reported by a consumer and describes the occurrence of RHEUMATIC DISORDER (rheumatism flair up) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RHEUMATIC DISORDER (rheumatism flair up). At the time of the report, RHEUMATIC DISORDER (rheumatism flair up) outcome was unknown.            Treatment and concomitants were not provided.
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: he is already past the 42 days for getting the second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (he is already past the 42 days for getting the second dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 03-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (he is already past the 42 days for getting the second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (he is already past the 42 days for getting the second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medications were provided    Reporter did not allow further contact
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Peripheral swelling, Urticaria
Clinical narrative: Some fingers and toes swell up after the 2nd dose; Hives on his body after the 2nd dose; Muscular pain in the bones of hand and feet after the 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Some fingers and toes swell up after the 2nd dose), URTICARIA (Hives on his body after the 2nd dose) and MYALGIA (Muscular pain in the bones of hand and feet after the 2nd dose) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Some fingers and toes swell up after the 2nd dose), URTICARIA (Hives on his body after the 2nd dose) and MYALGIA (Muscular pain in the bones of hand and feet after the 2nd dose). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Hives, at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (Some fingers and toes swell up after the 2nd dose) and MYALGIA (Muscular pain in the bones of hand and feet after the 2nd dose) outcome was unknown and URTICARIA (Hives on his body after the 2nd dose) had resolved.            No concomitant medications were reported.  The first dose was given on dominant upper arm  while as the second dose was given on Non dominant upper arm.    Treatment medication included Steroid shot   Patient stated that he saw his HCP who was going to send him to a Rheumatologist and another specialist.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Follow up received on 15-JUL-2021: Email was added, Outcome of  event hives updated to Recovered.
Sex: U
Vaccine: COVID19
Symptoms: Hypoaesthesia, Neck pain
Clinical narrative: I have numbness in my left foot and arm; severe neck pain; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (I have numbness in my left foot and arm) and NECK PAIN (severe neck pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unk) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (I have numbness in my left foot and arm) and NECK PAIN (severe neck pain). At the time of the report, HYPOAESTHESIA (I have numbness in my left foot and arm) and NECK PAIN (severe neck pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided by the reporter. No treatment information was provided.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: Sore arm after first dose; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm after first dose) and FATIGUE (Tiredness) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 035C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-May-2021, the patient experienced PAIN IN EXTREMITY (Sore arm after first dose) and FATIGUE (Tiredness). On 19-May-2021, PAIN IN EXTREMITY (Sore arm after first dose) and FATIGUE (Tiredness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient started with  sore arm and tiredness.No relevant concomitant medications were reported.  No treatment information was provided.     This case was linked to MOD-2021-225797 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis, Product dose omission issue
Clinical narrative: Had a cold; Missed second dose appointment, more than 42 days have passed since first dose.; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Had a cold) and PRODUCT DOSE OMISSION ISSUE (Missed second dose appointment, more than 42 days have passed since first dose.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (Had a cold) and PRODUCT DOSE OMISSION ISSUE (Missed second dose appointment, more than 42 days have passed since first dose.). At the time of the report, NASOPHARYNGITIS (Had a cold) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Missed second dose appointment, more than 42 days have passed since first dose.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product details was not reported.  Treatment details was not reported
Sex: F
Vaccine: COVID19
Symptoms: Breast swelling
Clinical narrative: Covid vaccine make your boobs grow; This spontaneous case was reported by a consumer and describes the occurrence of BREAST SWELLING (Covid vaccine make your boobs grow) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BREAST SWELLING (Covid vaccine make your boobs grow). At the time of the report, BREAST SWELLING (Covid vaccine make your boobs grow) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no treatment medication provided no concomitant medication provided
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Left sore arm; This spontaneous case was reported by an other health care professional and describes the occurrence of MYALGIA (Left sore arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Jun-2021, the patient experienced MYALGIA (Left sore arm). On 08-Jun-2021, MYALGIA (Left sore arm) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The  action taken for m-RNA-1273 Moderna COVID-19 vaccine is not applicable  No concomitant medications were provided  No treatment medications were provided.